The evidence field · updated daily

5,380 peptide studies,
read so you don't have to.

Every randomized trial, cohort, review and preclinical paper on the peptides people actually use — pulled from 5 primary sources, distilled into a plain-English digest, tagged by evidence strength, and laid out below as a living map of the field.

2,402 studies dated 2026 alone — the peptide literature is compounding.

Studies by publication year 1998–2026
PubMed Clinical trials Other sources

Where it comes from

  • PubMed 3,631
  • ClinicalTrials.gov 1,451
  • EuropePMC 235
  • PubChem 42
  • DailyMed 21

Evidence strength

  • Strong · trials & meta-analyses 757
  • Moderate · cohorts & reviews 564
  • Early · preclinical & in-vitro 1,819
  1. 2026-06-24 PubMed

    Pumicyclin A, a novel circular bacteriocin from *Bacillus pumilus*, shows broad-spectrum activity against Gram-positive foodborne pathogens

    The discovery and characterization of **pumicyclin A offers a promising natural antimicrobial agent for food biopreservation**, providing a safer, more consumer-friendly alternative to conventional chemical preservatives. Its potent acti…

  2. 2026-06-24 PubMed

    Review Maps Strategies to Mitigate Goat's Milk Casein Allergenicity for Hypoallergenic Infant Formulas

    This review provides a crucial roadmap for **designing safer, hypoallergenic goat's milk products**, particularly for **infant formula**. By consolidating diverse strategies—from `enzymatic hydrolysis` to `in silico` prediction—it offers…

  3. 2026-06-24 PubMed

    Fusarium graminearum orchestrates three-phase virulence cascade for progressive maize root rot

    This temporal framework provides unprecedented insight into how **Fusarium graminearum** systematically invades maize roots, offering a roadmap for novel anti-virulence strategies. Understanding the phase-specific coordination of tissue …

  4. 2026-06-24 PubMed

    Review Unpacks Gut Microbiome-Endocrine Axis, Detailing Microbial Metabolite Impact on Obesity and Therapeutic Strategies

    **Understanding the gut microbiome-endocrine axis is crucial for developing novel, targeted strategies to combat obesity and related metabolic diseases.** This review consolidates the complex interplay, offering a roadmap for researchers…

  5. 2026-06-24 PubMed

    Comprehensive review highlights `Acinetobacter baumannii` resistance mechanisms, emerging therapies including antimicrobial peptides, and vaccine development challenges

    This comprehensive review critically informs researchers, clinicians, and biohackers about the escalating threat posed by **Acinetobacter baumannii**, particularly its **MDR** and **XDR** forms. **The insights into its resistance mechani…

  6. 2026-06-24 PubMed

    Engineered W20-LT fusion protein ameliorates cognitive deficits and amyloid pathology in Alzheimer's mice

    This study presents a promising proof-of-concept for a multi-targeted therapeutic strategy in **Alzheimer's disease**. By combining Aβ oligomer recognition with enhanced microglial uptake and autophagy-associated clearance, **W20-LT** of…

  7. 2026-06-24 PubMed

    Lep5 R8-18, a modified scorpion peptide, enhances antibacterial activity, reduces hemolysis.

    This research introduces a promising strategy for developing new antibiotics, particularly relevant for infections resistant to current treatments. **The dual benefit of enhanced antibacterial activity coupled with reduced hemolytic toxi…

  8. 2026-06-24 PubMed

    CREBZF/c-Jun complex regulates ApoE expression, reducing cholesterol and influencing female steroidogenesis.

    This study unveils a critical regulatory axis involving **CREBZF**, `c-Jun`, and `ApoE` that directly impacts cholesterol transport and **female steroid hormone synthesis**. **Understanding this CREBZF/c-Jun/ApoE pathway provides a novel…

  9. 2026-06-24 PubMed

    Semaglutide's Multi-Organ Benefits in Type 2 Diabetes Stem from Broad Molecular Adaptations Across Inflammatory, Lipid, and ECM Pathways

    A comprehensive review details how semaglutide improves glycemic control, weight, and cardiovascular health by modulating inflammatory, lipid, and extracellular matrix pathways.

  10. 2026-06-24 PubMed

    Repurposed ramipril, carvedilol, metformin, and generic statins offer low-cost, high-impact cardiovascular prevention

    This analysis provides a critical framework for clinicians and policymakers to prioritize cardiovascular prevention strategies based on both clinical efficacy and economic sustainability. **Integrating cost-effectiveness into treatment d…

  11. 2001-05-08 ClinicalTrials.gov

    Norditropin® lyophilized and liquid somatropin formulations undergo safety evaluation in children with growth hormone deficiency

    Understanding the comparative safety of different **somatropin** formulations is crucial for optimizing treatment protocols for **children with growth hormone deficiency**. If one formulation demonstrates a superior safety profile or com…

  12. 2020-05-20 ClinicalTrials.gov

    Nurse Home-Visiting Program's Long-Term Impact on Offspring Chronic Disease Risk Explored in Longitudinal Cohort

    Understanding the long-term impact of early life interventions like nurse home-visiting programs is crucial for public health strategies. If this study reveals a significant reduction in chronic disease risk among offspring who received …

  13. 2025-09-01 ClinicalTrials.gov

    Suvorexant Proof-of-Concept Trial Evaluates Safety, Feasibility for Suicide Risk in MDD

    If successful, this trial could establish a foundation for **suvorexant** as a novel adjunctive therapy for **Major Depressive Disorder** patients with elevated suicide risk, potentially offering a new strategy beyond traditional antidep…

  14. 2026-06-24 ClinicalTrials.gov

    Liraglutide and add-on anti-diabetics investigated for inflammation, energy homeostasis in Type 2 Diabetes

    A study will observe how new add-on anti-diabetic drugs, including Liraglutide, affect inflammation and energy homeostasis in Type 2 Diabetes outpatients.

  15. 2015-11-05 ClinicalTrials.gov

    Randomized study compares PIEB and CEI for third trimester medical termination analgesia

    A randomized study compared Programmed Intermittent Epidural Bolus (PIEB) to Continuous Epidural Infusion (CEI) for third trimester medical termination of pregnancy analgesia.

  16. 2024-11-18 ClinicalTrials.gov

    Hair Cortisol Proposed as Objective Biomarker for Early Life Stress Regulation in Children

    Study aims to develop hair cortisol as an objective biomarker for stress regulation in young children exposed to adverse/positive childhood experiences.

  17. 2017-11-06 ClinicalTrials.gov

    Intranasal Oxytocin's Influence on Communication and Evolutionary Goals to be Explored

    Understanding how **intranasal oxytocin** influences communication and social behaviors could significantly impact therapeutic strategies for conditions characterized by social deficits, such as **autism spectrum disorder** or **social a…

  18. 2016-02-01 ClinicalTrials.gov

    Mallampati class changes before and after cesarean delivery evaluated to identify predictive factors

    Understanding the factors that predict changes in **Mallampati class** during **cesarean delivery** could significantly enhance **airway management protocols** in obstetric anesthesia. If specific physiological or procedural elements are…

  19. 2022-01-30 ClinicalTrials.gov

    Oxytocin and balloon catheter induction protocol for VBAC success in prior cesarean patients.

    A multi-center prospective observational study will assess oxytocin and balloon catheter induction for vaginal birth after cesarean (VBAC) success and safety in 924 women.

  20. 2018-11-20 ClinicalTrials.gov

    Intranasal Carbetocin (LV-101) Enters Phase 3 Trial for Prader-Willi Syndrome

    Intranasal **carbetocin** (LV-101) is being evaluated in a Phase 3 study for its effectiveness, safety, and tolerability in patients with **Prader-Willi Syndrome**.

  21. 2022-06-09 ClinicalTrials.gov

    Outpatient transcervical Foley balloon trial compares labor induction time and C-section risk against inpatient vaginal misoprostol

    If outpatient transcervical Foley balloon proves to be as effective and safe as inpatient misoprostol, it could significantly **transform labor induction protocols**. This shift could lead to reduced hospital stays, lower healthcare cost…

  22. 2014-12-15 ClinicalTrials.gov

    Liraglutide (Victoza®) Post-Marketing Surveillance Initiated to Assess Real-World Safety and Effectiveness

    A post-marketing surveillance study in Asia is evaluating the real-world safety and effectiveness of **liraglutide** (Victoza®) in type 2 diabetes patients on non-sulfonylurea antidiabetic agents.

  23. 2026-06-24 ClinicalTrials.gov

    Oral Semaglutide Successfully Treats HNF4A MODY Patient, Offering Alternative to Sulfonylureas

    This case report highlights a potentially significant shift in the management paradigm for **HNF4A MODY**. Traditionally, `sulfonylureas` are the go-to, but **oral semaglutide** offers a novel, non-sulfonylurea option. **For individuals …

  24. 2015-07-27 ClinicalTrials.gov

    Preliminary Study Initiates Assessment of MK-8521 Efficacy and Safety for Type 2 Diabetes

    **MK-8521** represents a potential new therapeutic agent for **Type 2 Diabetes** patients whose glycemic control is insufficient with metformin alone. If this preliminary study and subsequent trials demonstrate favorable efficacy and saf…

  25. 2026-06-24 ClinicalTrials.gov

    Liraglutide + canagliflozin combination aimed to prevent HGP rise, improve glycemic control in T2D.

    A clinical trial aimed to assess if **liraglutide** plus canagliflozin could prevent compensatory hepatic glucose production (HGP) and enhance glycemic control, weight loss, and blood pressure in Type 2 Diabetes.

  26. 2026-06-24 ClinicalTrials.gov

    Liraglutide's influence on gastrointestinal absorption of atorvastatin, lisinopril, griseofulvin, and digoxin investigated

    Liraglutide's potential drug-drug interactions with atorvastatin, lisinopril, griseofulvin, and digoxin, and its influence on intragastric pH, are being investigated.

  27. 2021-05-01 ClinicalTrials.gov

    East China Observational Study Aims to Identify High-Risk T2D Patients for GLP-1 RA Intervention

    This observational study is crucial for refining **Type 2 Diabetes** management by providing real-world insights into **ASCVD** risk stratification and the targeted use of **Glucagon-like peptide-1 receptor agonists** (GLP-1 RAs). **Iden…

  28. 2022-04-01 ClinicalTrials.gov

    Oral Semaglutide Real-World Efficacy in Italian Type 2 Diabetes Patients Explored in New Observational Study

    While no results are yet available, this type of real-world evidence study is vital for understanding how **oral semaglutide** performs outside of controlled clinical trials. **Real-world data can highlight adherence patterns, patient pr…

  29. 2018-06-18 ClinicalTrials.gov

    NNC0165-1562 and Semaglutide Co-Administered for Weight Management in Overweight or Obese Patients

    If successful, this trial could introduce a **novel combination therapy for obesity and overweight**, potentially offering enhanced weight loss compared to semaglutide alone. For individuals seeking advanced weight management solutions, …

  30. 2013-12-02 ClinicalTrials.gov

    Semaglutide Once-Weekly Efficacy and Safety Investigated Against Exenatide ER in Type 2 Diabetes

    **Comparing two established GLP-1R agonists** like semaglutide and exenatide ER is crucial for optimizing **Type 2 Diabetes** management. The results of this trial, once published, will offer direct head-to-head data, which is invaluable…

  31. 2021-01-15 ClinicalTrials.gov

    Oral Semaglutide Doses Up to 50 mg Explored for Enhanced Type 2 Diabetes Management

    This study carries substantial implications for the future landscape of **Type 2 Diabetes** management, particularly for patients seeking highly effective, non-injectable therapeutic options. Should higher doses of **oral semaglutide** (…

  32. 2026-07-01 ClinicalTrials.gov

    Tirzepatide to be investigated for reducing cannabis cue-reactivity in a pilot randomized crossover trial

    This pilot trial represents a crucial exploratory step in addressing the significant unmet medical need for effective pharmacological treatments for **Cannabis Use Disorder (CUD)**. If **tirzepatide** demonstrates a positive signal by re…

  33. 2024-11-01 ClinicalTrials.gov

    CRAVE Study to investigate semaglutide and tirzepatide impact on food cravings and diet quality in overweight/obese adults

    This study, once completed, could provide critical data for understanding the full spectrum of GLP-1RA effects beyond just weight loss. **Clinicians and individuals using GLP-1RAs could gain insights into how these medications specifical…

  34. 2022-10-06 ClinicalTrials.gov

    Tirzepatide's impact on metabolic adaptation and long-term weight regain to be investigated

    **Understanding the role of metabolic adaptation in weight regain is crucial for optimizing long-term obesity management.** If this study demonstrates that **tirzepatide** effectively mitigates adverse metabolic adaptations, it could pro…

  35. 2026-06-24 PubMed

    Hexahistidine-tagged melittin nanoassembly (NanoMel) boosts biofilm degradation and cuts toxicity for plant protection.

    This research offers a significant step towards **safer and more effective antimicrobial peptide applications in agriculture**. For biohackers or researchers exploring peptide delivery, the metal-coordination nanoassembly strategy provid…

  36. 2026-06-24 PubMed

    Global Obesity Epidemic Triples Since 1975, Redefined as Multisystem Disease, GLP-1/GIP Agonists Emerge as Key Therapies

    This comprehensive review underscores the urgent need for a paradigm shift in how **obesity** is understood and managed, moving beyond simple weight metrics to a multisystem disease framework. **For clinicians and biohackers**, the empha…

  37. 2026-06-24 PubMed

    iRGD-modified 3D exosomes delivering miR-99b-5p induce ferroptosis to inhibit colorectal cancer progression.

    iRGD-modified 3D exosomes loaded with miR-99b-5p significantly inhibited colorectal cancer growth and enhanced 5-FU efficacy in vivo by inducing ferroptosis.

  38. 2026-06-24 PubMed

    Melittin, a Honey Bee Venom Peptide, Exhibits Broad Anti-Cancer Properties Across Diverse Preclinical Models

    This comprehensive review underscores **melittin's potential as a powerful anti-cancer therapeutic**, highlighting its broad efficacy against multiple cancer hallmarks. For biohackers and clinicians, this means exploring novel, biologica…

  39. 2026-06-24 PubMed

    D4F HDL-mimetic peptide reverses APOE4-induced brain transcriptomic and lipidomic alterations in humanized mice

    This study provides compelling evidence that HDL-mimetic peptides like **D4F** can reverse key molecular alterations in the brain caused by the **APOE4** allele, a major genetic risk factor for **Alzheimer's disease**. **For individuals …

  40. 2026-06-24 PubMed

    Immunoproteasome inhibition protects retinal pigment epithelium from Aβ-induced degeneration via TNFα-NLRP3 pathway.

    This research provides a clearer understanding of how **Alzheimer's disease** pathology impacts retinal health, specifically the **RPE degeneration**. For those interested in neurodegenerative disease interventions, it highlights the **i…

  41. 2026-06-24 PubMed

    Bone-targeted LNP delivering anti-sclerostin antibody mRNA restores bone mass in ovariectomy osteoporosis.

    **This bone-targeted mRNA delivery strategy opens new avenues for treating osteoporosis and other skeletal disorders by overcoming the liver-centric delivery challenge of conventional LNPs.** For peptide users and biohackers, this highli…

  42. 2026-06-24 PubMed

    VicRK and LiaSR Two-Component Systems Exhibit Extensive Crosstalk Regulating *S. mutans* Virulence and Biofilm Formation

    This synthesis underscores the potential of targeting the **VicRK** and **LiaSR** systems as a novel anti-virulence strategy for **dental caries** and endodontic infections, offering an alternative to traditional antimicrobials that driv…

  43. 2026-06-24 PubMed

    γ-Secretase complex emerges as therapeutic target for Alzheimer's and cancer, from biochemistry to pathology

    Understanding the γ-secretase complex is crucial for developing targeted therapies for **Alzheimer's disease** and various cancers. **Modulating γ-secretase activity offers a promising strategy to intervene in disease progression**, movi…

  44. 2026-06-24 PubMed

    CRHBP-UCN2 Axis Critically Regulates Kidney Cancer Prognosis, Identifies CRHBP as Potential Anticancer Peptide Target

    This study significantly advances our understanding of **KIRC** progression by identifying the **CRHBP-UCN2 axis** as a critical regulator of prognosis and immune microenvironment remodeling. **CRHBP** emerges as a reliable prognostic bi…

  45. 2026-06-24 PubMed

    Multifunctional Nanotherapeutics Precisely Modulate ER Stress to Potentiate Cancer Immunotherapy

    This review highlights a transformative strategy for **cancer therapy** by leveraging nanotherapeutics to precisely modulate **ERS**, potentially overcoming resistance and enhancing immunotherapy. For clinicians and researchers, this sug…

  46. 2026-06-24 PubMed

    Peptides show promise for diagnosing and treating pancreatic cancer, pancreatitis, and diabetes

    **Peptides are poised to revolutionize the diagnosis and treatment of pancreatic diseases**, offering a path to more precise and effective interventions with potentially fewer side effects. For biohackers and clinicians, this review unde…

  47. 2026-06-24 PubMed

    Rehabilitation improves sleep and development in autistic children, linked to altered gut microbiome and specific metabolites like ornithine

    This study provides compelling evidence that **rehabilitation interventions can positively impact both clinical symptoms and gut microbiome profiles in autistic children**. The identified microbial-metabolic signatures, particularly the …

  48. 2026-06-24 PubMed

    Cytoplasmic and nuclear ERK signaling are essential for *Campylobacter jejuni* invasion and IL-8 secretion

    This research identifies host **ERK signaling** as a critical and potentially targetable pathway in *Campylobacter jejuni* infection. By demonstrating that both cytoplasmic and nuclear `ERK` are essential for bacterial invasion and `IL-8…

  49. 2026-06-24 PubMed

    GRPR-Targeted Radionuclide Theranostics Show Promising Diagnostic Value and Advancing Therapeutic Potential Across Multiple Cancers

    This review underscores a significant shift towards more precise and personalized oncology, offering a blueprint for future therapeutic strategies. **GRPR-targeted theranostics could enable earlier, more accurate cancer diagnosis and del…

  50. 2026-06-24 PubMed

    Melittin, an arthropod venom peptide, potently inhibits *Sporothrix* fungi and synergizes with itraconazole

    This study highlights **melittin** as a potent antifungal candidate against drug-resistant *Sporothrix* species, offering a novel therapeutic avenue beyond conventional treatments. The observed synergy with itraconazole is particularly s…

  51. 2026-06-24 PubMed

    Thymic APC networks critically shape T-cell selection, offering novel immune reprogramming strategies for autoimmune disorders

    This review significantly advances our understanding of T-cell development and provides a roadmap for novel therapeutic interventions in **autoimmune diseases**. **By pinpointing specific defects in thymic APC networks, clinicians and bi…

  52. 2026-06-24 PubMed

    IGF-1 mediates 38-54% of BMI-liver cancer risk, with lower IGF-1 levels linked to higher risk.

    This study provides compelling evidence that **IGF-1 is a key mediator in the link between obesity and liver cancer**, suggesting that maintaining healthy IGF-1 levels could be a strategy to mitigate risk. For individuals with high BMI, …

  53. 2026-06-24 PubMed

    Music interventions significantly boost breast milk volume and fat content, while reducing maternal stress in breastfeeding mothers.

    This meta-analysis provides compelling evidence for integrating music interventions into standard care for breastfeeding mothers, especially those experiencing stress or in challenging environments like the NICU. **Implementing music the…

  54. 2026-06-24 PubMed

    Uterine activity thresholds for Montevideo units, contraction frequency, and baseline tone predict neonatal acidemia

    This study provides **evidence-based thresholds for uterine activity monitoring** that can directly inform clinical practice during labor. By identifying specific `Montevideo units (MVUs)`, `contraction frequency`, and `baseline tone` li…

  55. 2026-06-24 PubMed

    Sonic Augmentation Technology™ (SAT) improves self-reported well-being and increases salivary oxytocin.

    **Sonic Augmentation Technology™ (SAT) offers a promising, non-invasive, and low-cost approach to enhance well-being and autonomic regulation, particularly for individuals struggling with anxiety and depression.** This could provide an a…

  56. 2026-06-24 PubMed

    Music's context-dependent influence on oxytocin, social bonding, and emotion regulation confirmed by systematic review

    This review provides critical insights for clinicians and music therapists, emphasizing that the therapeutic effects of music on social bonding and emotion regulation, mediated by **oxytocin**, are not universal but highly context-depend…

  57. 2026-06-24 PubMed

    Missed Oral Semaglutide Doses Impact Pharmacokinetic Concentrations Differently Than Other GLP-1 Therapies

    This research provides critical insights for clinicians and patients regarding the practical management of **oral semaglutide** therapy. **Understanding the differential impact of missed doses on oral semaglutide's PK profile is essentia…

  58. 2026-06-24 PubMed

    GLP-1 Receptor Agonists Cut Cardiorenal Events 16-21% in CKD Patients, Semaglutide Ranks Highest

    **GLP-1 RAs provide clinically meaningful cardiorenal protection in CKD patients, offering benefits that are additive to those of SGLT2 inhibitors.** This reinforces their crucial role in managing high-risk individuals with **CKD**, part…

  59. 2026-06-24 PubMed

    Orforglipron demonstrates hepatic safety profile similar to placebo in pooled Phase 3 trials for obesity and T2D

    This comprehensive pooled analysis provides strong reassurance regarding the hepatic safety of **Orforglipron**, an oral `GLP-1 RA`, for long-term use in individuals with **obesity** or **T2D**. Given the high prevalence of **non-alcohol…

  60. 2026-06-24 PubMed

    Semaglutide cuts major adverse cardiovascular events by 32% across diverse populations, despite GI side effects

    **Semaglutide offers marked and consistent cardiovascular risk reduction across a broad spectrum of patients and doses**, reinforcing its role beyond glycemic control and weight management. This finding suggests that individuals at risk …

  61. 2026-06-24 EuropePMC

    532nm KTP Long Pulse Laser Improves Facial Rosacea Erythema and Telangiectasia in Clinical Practice

    The 532nm KTP long pulse laser effectively treats facial rosacea, reducing erythema and telangiectasia with favorable tolerability.

  62. 2026-06-24 EuropePMC

    PEER team identifies top primary care studies from 2025, synthesizing key clinical advancements

    This annual review by the PEER team significantly streamlines the process for primary care clinicians to stay current with the latest evidence. **Practitioners can quickly access a vetted summary of high-impact research**, saving valuabl…

  63. 2026-06-24 PubMed

    Chimeric SLA-1*1502/mβ2m/PP7 complex structure reveals distinct peptide binding, optimizing mouse models for immunological research.

    This study provides a critical structural understanding for optimizing **immunological research models**. The finding that murine β2m significantly alters `MHC-I` complex formation and peptide binding mode means that simply expressing a …

  64. 2026-06-24 PubMed

    Nesfatin-1 mitigates calcium oxalate nephropathy in mice by modulating GPR12 and inhibiting PKCα/NADPH oxidase.

    This study provides the first evidence that **nesfatin-1** could be a potential therapeutic agent for **nephrocalcinosis** and **nephrolithiasis**, offering a novel approach beyond current treatments. The identification of `GPR12` recept…

  65. 2026-06-24 PubMed

    ATP-responsive DNA hydrogel enables on-demand FGF21 release, enhancing muscle cell proliferation and differentiation

    This ATP-responsive DNA hydrogel represents a significant step towards **precision regenerative medicine** for muscle injuries. For biohackers and clinicians, this technology could enable highly localized and controlled delivery of growt…

  66. 2026-06-24 PubMed

    Recent Advances Unravel γ-Secretase's Substrate Recognition, Drug Sites, and Physiological Roles

    **A deeper understanding of γ-secretase's mechanism and substratome is critical for developing safer and more effective Alzheimer's disease (AD) therapies.** Previous attempts at directly inhibiting γ-secretase led to severe side effects…

  67. 2026-06-24 PubMed

    Digital Twin Model Optimizes Cell-Seeding for Nerve Tissue Engineering, Enhancing Angiogenesis Factors

    This digital twin approach represents a significant leap for **nerve tissue engineering**, offering a pathway to dramatically accelerate the development and optimization of regenerative strategies. For researchers and clinicians, it mean…

  68. 2026-06-24 PubMed

    Circulating Biomarkers Evolve as Essential Pillars for Heart Failure Diagnosis and Prognosis

    This comprehensive review underscores the evolving role of **biomarkers in heart failure**, shifting from simple diagnostic aids to crucial tools for personalized patient management. **Clinicians can leverage a broader panel of biomarker…

  69. 2026-06-24 PubMed

    mKRAS-VAX Peptide Vaccine with Dual Checkpoint Blockade Safely Boosts T-Cell Immunity in Metastatic Colorectal Cancer

    This study provides compelling evidence that a **mutant KRAS peptide vaccine can safely enhance anti-tumor immunity in MMRp/MSS colorectal cancer** when combined with dual immune checkpoint blockade. For patients with **MMRp/MSS CRC**, w…

  70. 2026-06-24 PubMed

    Gabapentin and α2δ1 C-terminal peptide reduce left atrial hypertrophy in ischemic heart failure rats

    This research identifies `α2δ1` as a promising novel therapeutic target for **left atrial remodeling (LAR)** and **atrial fibrillation (AF)** in **ischemic heart failure**. **Repurposing existing drugs like gabapentin, or developing spec…

  71. 2026-06-24 PubMed

    Pediatric Hypertension Drives Cardiovascular-Kidney-Metabolic Syndrome Progression, Influenced by Antenatal Risks and Social Determinants

    **Early intervention focusing on antenatal risks and social determinants of health is critical to slow CKM progression in children.** This review underscores that managing **pediatric hypertension** is not just about blood pressure contr…

  72. 2026-06-24 PubMed

    MOG-AMP-B microparticles loaded with myelin antigen reverse experimental autoimmune encephalomyelitis by promoting tolerogenic B cell presentation

    This research presents a novel, highly antigen-specific therapeutic strategy for **Multiple Sclerosis** that directly targets B cells to induce tolerance, a mechanism largely untargeted by existing antigen-specific approaches. **By promo…

  73. 2026-06-24 PubMed

    Intranasal oxytocin shows no significant effect on alcohol-related outcomes in meta-analysis of six RCTs

    This comprehensive meta-analysis suggests that **intranasal oxytocin is not currently supported as an effective adjunctive treatment for Alcohol Use Disorder (AUD)** based on the aggregated evidence from existing randomized controlled tr…

  74. 2026-06-24 PubMed

    Review synthesizes environmental and management impacts on mammary development and lactation capacity in dairy animals

    This review underscores the critical need for dairy producers to shift from reactive management to **proactive strategies that optimize the rearing environment and leverage mammary epithelial proliferative potential**. Understanding how …

  75. 2026-06-24 PubMed

    Liraglutide-potentiated insulin secretion requires Type IIB PKA in mice, regulating KATP and Ca2+ channels.

    This study clarifies the specific role of **Type IIB PKA** as a critical mediator for `GLP-1R` agonists like **liraglutide** in enhancing insulin secretion. For peptide users and clinicians, this research highlights the importance of the…

  76. 2026-06-24 PubMed

    Semaglutide treatment for Male Obesity-Associated Hypogonadism alters DNA methylation and miRNA patterns.

    This research provides initial insights into the epigenetic mechanisms underlying **Semaglutide's** effects in **MOSH**, suggesting its benefits extend beyond weight loss to direct cellular programming. **Understanding these epigenetic s…

  77. 2026-06-23 PubMed

    Cladosporium sphaerospermum fungus attenuates cadmium toxicity in wheat by modulating specific gene expression and metabolites.

    This research provides a compelling basis for developing **eco-friendly and sustainable strategies to combat heavy metal contamination in agriculture**. For farmers and agricultural scientists, *Cladosporium sphaerospermum* emerges as a …

  78. 2026-06-23 PubMed

    Pulmonary Copper Oxide Nanoparticles Induce Systemic Prothrombotic State and Oxidative Stress in Mice

    This study provides critical insights into the systemic risks associated with pulmonary exposure to copper oxide nanoparticles, highlighting that even acute exposure can trigger a cascade of adverse events. For individuals in industrial …

  79. 2026-06-23 PubMed

    Partitioned Polygenic Risk Scores (pPRS) Associate with Insulin Dynamics and Type 2 Diabetes Incidence in Prediabetes

    This research refines our understanding of how genetic predisposition, specifically through **partitioned polygenic risk scores (pPRS)**, influences the progression from **prediabetes** to **Type 2 Diabetes**. For clinicians and individu…

  80. 2026-06-23 PubMed

    Qingwen Baidu Decoction (QBD) computationally targets CXCL10, EZH2, and EPHB2 to modulate dengue fever inflammation and immunity.

    This computational study provides a crucial theoretical framework for understanding how **Qingwen Baidu Decoction (QBD)** may combat **dengue fever**, offering insights into its multi-faceted action. **Identifying specific gene targets l…

  81. 2026-06-23 PubMed

    CRKL amplification synergizes with mechanical stress to dually activate YAP pathways, driving plantar melanoma progression.

    This study provides a crucial understanding of why **plantar melanoma** preferentially develops in weight-bearing areas and identifies a novel oncogenic driver. **Targeting CRKL could offer a new therapeutic strategy for patients with ac…

  82. 2026-06-23 PubMed

    Pyroptosis emerges as critical link in diabetes-associated bone loss, affecting all major bone cells

    Understanding the molecular regulation and temporal dynamics of `pyroptosis` offers a **novel therapeutic avenue** for preserving skeletal health in diabetic patients. Current treatments for **diabetic osteoporosis (DOP)** often focus on…

  83. 2026-06-23 PubMed

    Diabetic Gastroparesis Pathophysiology Disrupts Insulin Timing, Necessitating Personalized Therapeutic Strategies

    For individuals managing **diabetes**, particularly those with **diabetic gastroparesis**, this review underscores the critical need for a **personalized therapeutic strategy** to stabilize metabolic control. The findings highlight that …

  84. 2026-06-23 PubMed

    Dual GLP-1R agonist and anti-IL-17A therapy suppresses obesity-driven leukemia in PTPN11-mutant mice

    This study provides a critical mechanistic link between **obesity**, `IL-17A`-driven inflammation, and `SHP2`-mutant myeloid leukemias, offering a novel therapeutic avenue. For **obese patients with myeloid malignancies**, particularly t…

  85. 2026-06-23 PubMed

    Framework proposes risk-based combination therapy with SGLT2 inhibitors, MRAs, and GLP-1 receptor agonists for CKD.

    **Clinicians can now consider a structured, risk-based approach to combine SGLT2 inhibitors, MRAs, and GLP-1 receptor agonists for CKD patients**, potentially reducing residual kidney and cardiovascular risks more effectively than monoth…

  86. 2026-06-23 PubMed

    Nisin synergizes with doxorubicin, enhancing breast cancer cell apoptosis and DNA damage via membrane permeabilization.

    This study highlights a novel strategy for **enhancing breast cancer therapy by combining nisin with doxorubicin**, potentially allowing for lower DOX doses and reduced systemic toxicity. The findings suggest that nisin's membrane-modula…

  87. 2026-06-23 PubMed

    Epidermal γδ T cells expressing TNFR2 adopt an IL-17 phenotype in psoriasis, revealing new therapeutic targets.

    This research identifies `TNFR2` on epidermal γδ T cells as a novel and specific cellular target in **psoriasis** pathogenesis. **Targeting TNFR2 on this discrete subset of epidermal γδ T cells could offer a more precise and potentially …

  88. 2026-06-23 PubMed

    Managed Care Playbook Proposes GLP-1 Prior Authorization Friction Index to Streamline Access and Reduce Patient Abandonment

    This playbook offers a critical tool for **managed care organizations** to proactively address the often-overlooked operational friction in **GLP-1** prior authorization. By implementing the `PA Friction Index`, payers can move beyond re…

  89. 2026-06-23 PubMed

    Medicare's $35 Insulin Cost Cap Boosts Basal Insulin Persistence by 1.3 Percentage Points

    **The Medicare insulin cost cap directly improves patient adherence to basal insulin, potentially leading to better health outcomes and reduced economic burden for beneficiaries.** This study provides compelling evidence that policy inte…

  90. 2026-06-23 PubMed

    M.R. stapled peptide hydrogel promotes skeletal muscle repair after cryolesion injury

    This research introduces a potentially transformative approach for treating severe **skeletal muscle injuries**, offering a novel peptide-based therapeutic that addresses multiple facets of regeneration simultaneously. **M.R.**, delivere…

  91. 2026-06-23 PubMed

    Zinc Finger Proteins Emerge as Key Regulators and Therapeutic Targets in Organ Fibrosis

    **Targeting ZNF-mediated pathways** represents a novel and potentially highly effective therapeutic strategy for organ fibrosis, addressing a significant unmet medical need. This research suggests that modulating specific ZNFs could inte…

  92. 2026-06-23 PubMed

    Endobody nanobody-CPP chimeras achieve genetically encodable degradation of membrane and extracellular proteins

    This innovative Endobody platform significantly broadens the scope of targeted protein degradation, offering a genetically encodable and receptor-independent approach to target membrane and extracellular proteins. **The ability to degrad…

  93. 2026-06-23 PubMed

    Oxytocin Induces Adipocyte Lipolysis in Lactating Mammary Gland, Boosting Milk Lipid Content

    This finding fundamentally changes our understanding of **how milk fat content is regulated**, moving beyond general hormonal control to a specific cellular mechanism. For clinicians and biohackers focused on optimizing maternal and infa…

  94. 2026-06-23 PubMed

    Semaglutide cut %BMIp95 by 22.9 percentage points at 18 months in children and young people with severe obesity

    This updated data provides compelling evidence for **semaglutide** as an effective intervention for **severe and complicated pediatric obesity**, a population with limited treatment options. The observed significant reductions in **%BMIp…

  95. 2026-06-23 PubMed

    Semaglutide delivers greater real-world weight loss and HbA1c reduction than dulaglutide in type 2 diabetes.

    This real-world data provides strong evidence that **semaglutide offers superior weight loss and glycemic control compared to dulaglutide** in patients with **type 2 diabetes**, particularly within an urban, predominantly African America…

  96. 2026-06-23 PubMed

    Tirzepatide, a dual GIP/GLP-1 agonist, achieves exceptional glycemic control and up to 20.9% weight reduction.

    This comprehensive analysis underscores that **Tirzepatide offers a new benchmark for managing type 2 diabetes and obesity**, potentially leading to superior outcomes compared to previous single-incretin therapies. For individuals strugg…

  97. 2026-06-23 PubMed

    Macadamia peptide MPAF alleviates DSS-induced ulcerative colitis in mice by suppressing NF-κB/NLRP3 pathway

    Macadamia nut-derived peptide **MPAF** significantly reduced inflammation and oxidative stress in DSS-induced ulcerative colitis mice, protecting the intestinal barrier.

  98. 2026-06-23 PubMed

    Teplizumab, an anti-CD3 antibody, delays Type 1 Diabetes progression from stage 2 to 3

    **Teplizumab's FDA approval marks a paradigm shift in Type 1 Diabetes management**, offering the first therapeutic option to delay disease onset rather than solely manage symptoms. For individuals at high risk (stage 2 T1D), this means a…

  99. 2026-06-23 PubMed

    Biological DMARDs Stabilize Bone Matrix Marker Pentosidine in Rheumatoid Arthritis Remission

    In rheumatoid arthritis patients aged ≥50, biological/targeted synthetic DMARDs prevented pentosidine increase in remission, suggesting better long-term bone quality.

  100. 2026-06-23 PubMed

    Increased Right Ventricular Afterload Predicts 2.2-Fold Higher 3-Year Mortality in Hospitalized AECOPD Patients

    This study underscores the critical importance of early cardiac assessment in hospitalized **AECOPD** patients. **Identifying increased RV afterload via echocardiography within 48 hours of admission can significantly improve risk stratif…

Go deeper on one peptide